全文获取类型
收费全文 | 810篇 |
免费 | 44篇 |
国内免费 | 31篇 |
专业分类
儿科学 | 32篇 |
妇产科学 | 7篇 |
基础医学 | 88篇 |
口腔科学 | 13篇 |
临床医学 | 64篇 |
内科学 | 172篇 |
皮肤病学 | 4篇 |
神经病学 | 150篇 |
特种医学 | 81篇 |
外科学 | 114篇 |
综合类 | 14篇 |
预防医学 | 51篇 |
眼科学 | 2篇 |
药学 | 55篇 |
中国医学 | 7篇 |
肿瘤学 | 31篇 |
出版年
2023年 | 2篇 |
2022年 | 7篇 |
2021年 | 17篇 |
2020年 | 15篇 |
2019年 | 16篇 |
2018年 | 17篇 |
2017年 | 9篇 |
2016年 | 11篇 |
2015年 | 19篇 |
2014年 | 18篇 |
2013年 | 30篇 |
2012年 | 32篇 |
2011年 | 44篇 |
2010年 | 26篇 |
2009年 | 25篇 |
2008年 | 42篇 |
2007年 | 49篇 |
2006年 | 32篇 |
2005年 | 45篇 |
2004年 | 20篇 |
2003年 | 23篇 |
2002年 | 28篇 |
2001年 | 51篇 |
2000年 | 25篇 |
1999年 | 32篇 |
1998年 | 21篇 |
1997年 | 11篇 |
1996年 | 11篇 |
1995年 | 18篇 |
1994年 | 16篇 |
1993年 | 7篇 |
1992年 | 13篇 |
1991年 | 13篇 |
1990年 | 12篇 |
1989年 | 17篇 |
1988年 | 11篇 |
1987年 | 14篇 |
1986年 | 12篇 |
1985年 | 6篇 |
1984年 | 10篇 |
1983年 | 8篇 |
1982年 | 8篇 |
1981年 | 5篇 |
1979年 | 5篇 |
1977年 | 8篇 |
1976年 | 6篇 |
1975年 | 4篇 |
1968年 | 5篇 |
1967年 | 4篇 |
1965年 | 1篇 |
排序方式: 共有885条查询结果,搜索用时 31 毫秒
1.
2.
A. Rocco J. Afra M. Toscano G. Sirimarco L. Di Clemente M. Altieri G. L. Lenzi V. Di Piero 《European journal of neurology》2007,14(12):1378-1382
The intensity dependence of the auditory-evoked potentials (IDAP) is inversely related to serotonergic tone. Depression is frequently observed after stroke, associated with cognitive impairment and increased mortality. Aim of this study was to investigate the serotonergic tone in acute stroke patients by IDAP. Consecutive patients with an acute stroke admitted in our stroke unit were evaluated using clinical and instrumental examinations and compared with healthy controls. The IDAP was calculated as the linear amplitude/stimulus intensity function (ASF) slope, by measuring the peak-to-peak amplitude of Nl-P2 on four blocks of different stimulus intensities. Twenty patients were enrolled; 11 had a right brain infarction; nine had depressive symptoms (DS). The ASF slope of the auditory-evoked potentials was markedly increased in stroke patients compared with controls ( P = 0.021). Stroke patients with DS had a significant steeper ASF slope than controls ( P = 0.017). There was no statistical difference in ASF slope between stroke patients without DS and controls. Post-stroke depression pathophysiology is still debated. Our study suggests that in acute stroke patients with DS, there is a direct involvement of the serotonergic system, regardless the degree of disability and the site of the lesion. 相似文献
3.
7-甲氧基-4′-羟基-3′-二乙胺甲基异黄酮(MHDF)对大鼠血流动力学和主动脉的作用 总被引:2,自引:0,他引:2
本实验观察了MHDF对整体大鼠血流动力学和离体大鼠胸主动脉的作用。结果表明iv MHDF(3~12.8 mg/kg)能降低大鼠左心室±dp/dtmax,Vmax,Vpm和LVSP,延长T-dp/dtmax,减慢心率。MHDF还能舒张大鼠胸主动脉,ED50为6.5×10-6mol/L;非竞争拮抗NA和CaCl2致主脉收缩,pD2′为3.11±0.21和3.73±0.07;抑制高K+致主动脉收缩,IC50为1.76×10-5mol/L。提示MHDF对血管的作用与α受体阻断剂不同,而可能与钙拮抗有关。 相似文献
4.
5.
Ennio Toscano Alessandro Simonati Yasuhiro Indo Generoso Andria 《Annals of neurology》2003,53(3):418-419
6.
7.
T lymphocyte activation is associated with viral replication in chronic hepatitis B virus infection of childhood. 总被引:2,自引:0,他引:2 下载免费PDF全文
A Vegnente S Guida A Lobo-Yeo L Alviggi H Daniels P Toscano V Nuzzo G Mieli-Vergani D Vergani 《Clinical and experimental immunology》1991,84(2):190-194
Activated circulating T lymphocytes expressing HLA-DR (mean +/- s.d. 11.0 +/- 5.2%) or interleukin-2 receptor (IL-2R) (2.1 +/- 1.7%) were significantly increased in 63 children with chronic hepatitis B virus (HBV) infection when compared with 33 age-matched healthy controls (3.0 +/- 1.3%, P less than 0.01, and 0.1 +/- 0.4%, P less than 0.01). HBeAg-positive patients had higher percentage of DR (11.9 +/- 5.1%) or IL-2R (2.4 +/- 1.7%) positive T lymphocytes than anti-HBe-positive children (7.4 +/- 3.6% and 1.1 +/- 1.5%, P less than 0.01 and P = 0.02 respectively). Similarly, HBV DNA-positive patients had higher percentage of DR (10.5 +/- 3.3) or IL-2R (3.2 +/- 1.7%) positive T cells than HBV DNA-negative children (6.6 +/- 2.8% and 1.2 +/- 1.5%, P less than 0.01 for both). There was a positive correlation between percentage of DR positive T lymphocytes and levels of HBV DNA. Sixty-two per cent of the DR-positive T lymphocytes were cytotoxic/suppressor and 35% helper/inducer. The relationship between viral replication and T lymphocyte activation is discussed. 相似文献
8.
Louise B. Russell Sun-Young Kim Cristiana Toscano Ben Cosgriff Ruth Minamisava Ana Lucia Andrade Colin Sanderson Anushua Sinha 《Vaccine》2021,39(1):158-166
BackgroundThis paper compares cost-effectiveness results from two models of maternal immunization to prevent pertussis in infants in Brazil, one static, one dynamic, to explore when static models are adequate for public health decisions and when the extra effort required by dynamic models is worthwhile.MethodsWe defined two scenarios to explore key differences between static and dynamic models, herd immunity and time horizon. Scenario 1 evaluates the incremental cost/DALY of maternal acellular pertussis (aP) immunization as routine infant vaccination coverage ranges from low/moderate up to, and above, the threshold at which herd immunity begins to eliminate pertussis. Scenario 2 compares cost-effectiveness estimates over the models’ different time horizons. Maternal vaccine prices of $9.55/dose (base case) and $1/dose were evaluated.ResultsThe dynamic model shows that maternal immunization could be cost-saving as well as life-saving at low levels of infant vaccination coverage. When infant coverage reaches the threshold range (90–95%), it is expensive: the dynamic model estimates that maternal immunization costs $2 million/DALY at infant coverage > 95% and maternal vaccine price of $9.55/dose; at $1/dose, cost/DALY is $200,000. By contrast, the static model estimates costs/DALY only modestly higher at high than at low infant coverage. When the models’ estimates over their different time horizons are compared at infant coverage < 90–95%, their projections fall in the same range.ConclusionsStatic models may serve to explore an intervention’s cost-effectiveness against infectious disease: the direction and principal drivers of change were the same in both models. When, however, an intervention too small to have significant herd immunity effects itself, such as maternal aP immunization, takes place against a background of vaccination in the rest of the population, a dynamic model is crucial to accurate estimates of cost-effectiveness. This finding is particularly important in the context of widely varying routine infant vaccination rates globally.Clinical Trial registryClinical Trial registry name and registration number: Not applicable. 相似文献
9.
10.
Sun-Young Kim Kyung-Duk Min Sung-mok Jung Louise B. Russell Cristiana Toscano Ruth Minamisava Ana Lucia S. Andrade Colin Sanderson Anushua Sinha 《Vaccine》2021,39(1):147-157
ObjectiveThis study evaluates the cost-effectiveness of maternal acellular pertussis (aP) immunization in low- and middle-income countries using a dynamic transmission model.MethodsWe developed a dynamic transmission model to simulate the impact of infant vaccination with whole-cell pertussis (wP) vaccine with and without maternal aP immunization. The model was calibrated to Brazilian surveillance data and then used to project health outcomes and costs under alternative strategies in Brazil, and, after adjusting model parameter values to reflect their conditions, in Nigeria and Bangladesh. The primary measure of cost-effectiveness is incremental cost (2014 USD) per disability-adjusted life-year (DALY).ResultsThe dynamic model shows that maternal aP immunization would be cost-effective in Brazil, a middle-income country, under the base-case assumptions, but would be very expensive at infant vaccination coverage in and above the threshold range necessary to eliminate the disease (90–95%). At 2007 infant coverage (DTP1 90%, DTP3 61% at 1 year of age), maternal immunization would cost < $4,000 per DALY averted. At high infant coverage, such as Brazil in 1996 (DTP1 94%, DTP3 74% at 1 year), cost/DALY increases to $1.27 million. When the model’s time horizon was extended from 2030 to 2100, cost/DALY increased under both infant coverage levels, but more steeply with high coverage. The results were moderately sensitive to discount rate, maternal vaccine price, and maternal aP coverage and were robust using the 100 best-fitting parameter sets. Scenarios representing low-income countries showed that maternal aP immunization could be cost-saving in countries with low infant coverage, such as Nigeria, but very expensive in countries, such as Bangladesh, with high infant coverage.ConclusionA dynamic model, which captures the herd immunity benefits of pertussis vaccination, shows that, in low- and middle-income countries, maternal aP immunization is cost-effective when infant vaccination coverage is moderate, even cost-saving when it is low, but not cost-effective when coverage levels pass 90–95%. 相似文献